The influence of hormone replacement therapy on the quality of life of women in menopause
Authors:
R. Bužgová; J. Kanioková
Authors‘ workplace:
Ústav ošetřovatelství a porodní asistence, Lékařská fakulta, Ostravská univerzita, Ostrava, vedoucí pracoviště doc. PhDr. D. Jarošová, Ph. D.
Published in:
Ceska Gynekol 2013; 78(5): 420-426
Category:
Original Article
Overview
Objective:
The objective of the study was to find out the quality of life of women in menopause and the extent of their menopausal symptoms in relation with hormone replacement therapy.
Design:
Interventional study.
Setting:
Institute of Nursing and Midwifery, Faculty of Medicine, the University of Ostrava.
Methods:
A sample was made up of 136 women from 41 to 58 years, who started to take hormone replacement therapy in order to improve their menopausal symptoms. For the assessment of the quality of life the WHOQOL – BREF questionnaire was used, and for the assessment of menopausal symptoms a Czech version of the standardized The Menopause - Specific Quality of Life Questionnaire MENQOL was used. Both questionnaires were given to the women twice – before the treatment was started and six months later.
Results:
When comparing the quality of life in relation with the treatment we found out a significantly better assessment of the quality of life in all domains of the WHOQOL-BREF questionnaire, as well as in individual items of the assessment of the overall quality of life (Q1) and health (Q2), and also in all domains of the questionnaire of menopausal symptoms MENQOL, six months after the replacement treatment was initiated. Before the treatment women pointed out the biggest problems with weight gain (4.2), avoiding intimate relationships (4.1), hot flashes (4.0), the changes of the skin (3.9), night sweats (3.9), feelings of fatigue (3.9) and the loss of energy (3.7). Out of 28 individual items of the questionnaire MENQOL a subjective improvement in the perception of menopausal symptoms were in 26 items, the biggest difference was in the item of night sweats (1.7), hot flashes (1.6), feelings of loss of energy (1.0) and fatigue (0.8).
Conclusion:
Hormone replacement therapy improves subjective assessment of the quality of life of women and the extent of menopausal symptoms already six months after a treatment initiation.
Keywords:
hormone replacement therapy – quality of life – menopause
Sources
1. Blumel, JE., Castelo-Branco, C., Binfa, L., et al. Quality of life after the menopause: a population study. Maturitas, 2000, 34, 1, p. 17–23.
2. Dragomírecká, E., Bartoňová, J. WHOQOL – BREF WHOQOOL – 100. 1. vyd. Praha: Psychiatrické centrum Praha, 2006, 92 s.
3. Fait, T. Klimakterium a hormonální substituční terapie. Moderní babictví, 2004, 3, 1, s. 5.
4. Fait, T. Hormonální substituční terapie a kardiovaskulární systém. Med pro Praxi, 2008, 5, 2, s. 70–73.
5. Fait, T. Možnosti objektivizace akutního klimakterického syndromu. Klimakt Med., 2008, 13, 1, s. 30–35.
6. Fait, T. Přechodem bez obav. 1. vyd. Praha: Maxdorf, 2010, 85 s.
7. Hess, R., Thurston, RC., Hays, RD., et al. The impact of menopause on health-related quality of life: results from the STRIDE longitudinal study. Qual Life Res., 2012, 21, 3, p. 535–544.
8. Hlatky, M., Boothroyd, D., Vittinghoff, E., et al. Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy. JAMA, 2002, 287, 5, p. 591–597.
9. Koliba, P. Kontroverze v perimenopauze a postmenopauze. Prakt Gyn, 2005, 9, 2, s. 24–26.
10. LaCroix, AZ., Freeman, EW., Larson, J., et al. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas, 2012, 73, 4, p. 361–368.
11. Limouzin-Lamothe, MA., Mairon, N., Joyce, CRB., et al. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol, 1994, 170, 2, p. 618–624.
12. Moilanen, J., Aalto, A., Raitanen, J., et al. Physical activity and change in quality of life during menopause an 8-year follow-up study. Health Qual Life Outcomes, 2012, 10, 8.
13. Moravcová, M., Mareš, J. Nástroje pro hodnocení kvality života žen po menopauze. Kontakt, 2011, 13, 4, s. 434–442.
14. Nappi, RE., Lachowky, M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas, 2009, 63, p. 138–141.
15. Pines, A., Sturdee, DW., MacLennan, AH. Quality of life and the role of menopausal hormone therapy. Climacteric, 2012, 15, 3, p. 213–216.
16. Poomalar, GK., Arounassalame, B. The quality of life during and after menopause among rural women. J Clin Diag Resh, 2013, 7, 1, p. 135–139.
17. Vrablík, M. Kardiovaskulární riziko a hormonální substituční léčba v menopauze. Interní Med., 2009, 11, 5, s. 207–210.
18. Zollner, YF., Acquadro, C., Schaefer, M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res, 2005, 14, 2, p. 309–327.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2013 Issue 5
Most read in this issue
- Incarcerated uterus in pregnancy – pitfalls of diagnosis, clinical course and therapy: two case reports
- Risk factors for endometrial cancer
-
Pregnancy and delivery in a patient with pure 46,XY karyotype
Summary of actual knowledge about XY women - Doctor’s specialty training in obstetrics and gynecology at university medical schools: 2012–2013